1.800.THE FIRM | 1.800.843.3476
The Cochran Firm Legal Blog
With Office Locations Nationwide
Monday, October 6, 2014
Eli Lilly Facing Suit Over Misleading Advertising
Eli Lilly is being sued over allegedly misleading advertising
regarding Axiron, the company’s testosterone replacement drug. According to the
plaintiff in this case, Eli Lilly mounted an aggressive campaign, marketing
Axiron as a treatment for “Low-T,” despite the product not being approved by
the FDA for such use. Eli Lilly is one of a handful of pharmaceutical companies
facing lawsuits over false advertising and personal injury resulting from use
of these types of potentially dangerous drugs.
Axiron, like all testosterone replacement therapies, was
approved to treat very specific conditions, but heavily marketed as a cure-all for
issues as diverse as depression, loss of muscle mass, and sexual dysfunction. Unfortunately,
while claims of the amazing benefits of testosterone medications remain
unproven, the dangers posed by these drugs are now well known.
Testosterone therapy is linked to an increased risk for
heart attack, particularly in men over the age of 65. When prescribed as a
lifestyle drug to treat ED and low libido, men are placed at an increased risk
for little to no known benefit.
If you or someone you love has suffered a heart attack after
taking a testosterone replacement medication, please contact The Cochran
Firm to schedule a free consultation. We maintain offices throughout the
United States and accept clients from all areas of the country.
posted by Admin at 6:44 AM
<< Home